Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 39,037 |
|
|||||
| News | (1) | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| MIRA Pharmaceuticals Inc | MIRA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0343 | 5.24% | 0.6893 | 08:35:30 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.655 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 32 | 39,037 | - | 0.6309 - 7.9799 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:35:30 | formt | 154 | $ 0.6893 | USD |
MIRA Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 9.61M | 14.78M | - | 0 | -11.98M | -0.81 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
MIRA Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MIRA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.725 | 0.7699 | 0.6309 | 0.6924987 | 60,273 | -0.0357 | -4.92% |
| 1 Month | 0.869 | 0.9171 | 0.6309 | 0.7436215 | 49,269 | -0.1797 | -20.68% |
| 3 Months | 0.9922 | 1.84 | 0.6309 | 1.48 | 619,075 | -0.3029 | -30.53% |
| 6 Months | 3.90 | 6.40 | 0.6309 | 1.74 | 455,538 | -3.21 | -82.33% |
| 1 Year | 7.00 | 7.9799 | 0.6309 | 2.09 | 322,439 | -6.31 | -90.15% |
| 3 Years | 7.00 | 7.9799 | 0.6309 | 2.09 | 322,439 | -6.31 | -90.15% |
| 5 Years | 7.00 | 7.9799 | 0.6309 | 2.09 | 322,439 | -6.31 | -90.15% |
MIRA Pharmaceuticals Description
| MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland. |
